Improve Outcomes and Star Ratings Through Pharmacy Partnership

  • April 01, 2020
  • 1:00 PM – 2:00 PM ET
  • online

Overall – clinical performance that supports value-based care design to drive better outcomes.

  • With value-based care models on the rise it is important to partner with a pharmacy that ensures the programs, services and capabilities offered support patient care.
  • Currently, it is estimated that 50% of patients are not adherent to their prescribed medications. The cost of nonadherence has been estimated at $100 billion to $289 billion annually. When talking to our patients, we found that the No. 1 controllable barrier to adherence is forgetfulness. The No. 2 controllable barrier is no refills remaining.
  • Objective of having Star Ratings – the market is increasing its focus on clinical performance as the percentage of Medicare Advantage lives in a plan of at least 4 Stars has more than doubled since 2013.

What attendees will learn: 

  • New ideas on how they can work with their pharmacy partners, beyond just a pharmacy network
  • Innovation; how pharmacies are delivering care
  • The power data sharing has on achieving desired results


Mike Umbleby, RPh
Vice President, Clinical Performance

Mike is Vice President of Clinical Performance at Walgreens, leading a team responsible for setting the strategic direction for Walgreens clinical performance, medication adherence, enterprise business-to-business marketing and product innovation to support payer and plan sponsor partners. He began his career at Walgreens in 1996 where he held various roles including pharmacy management and clinical oversight across several stores and regions. In 2008, Mike moved to Walgreens corporate headquarters and has held multiple leadership positions where he was responsible for launching enterprise-wide change initiatives across the organization, overseeing pharmacy innovation projects, and leading sales operations and client services for the Market Access sales and account management team. Mike received his Bachelor of Science in Pharmacy from the University of Pittsburgh.

Dorothy (Chrzaszcz) Loy, PharmD, MBA
Director of Clinical Performance Strategy

Dorothy is Director of Clinical Performance Strategy at Walgreens, she leads a team responsible for the development of the adherence and clinical performance strategies across over 9,000 pharmacies. Dorothy creates forward thinking strategies to execute on with plan sponsors and PBMs that help shape the future of value based contracts. She helps identify opportunities for pharmacists to further their roles in the adherence space by taking an active role in quality metric discussions that impact pharmacy as well as helping design innovative programs that allow pharmacists to practice at the top of their license. Dorothy harnesses the strengths of partnerships by collaborating with the health plans, PBMs, health care organizations, patient advocacy groups, charity organizations, providers, pharmaceutical manufacturers and government teams to drive meaningful business value and to improve patient care outcomes.

Dorothy has more than 13 years of experience in pharmacy. She began her career as a retail pharmacist before moving to Walgreens corporate headquarters where she has held various leadership roles in several divisions including clinical, technology, innovation and strategy. Dorothy earned a PharmD from Drake University School of Pharmacy and an MBA from Drake University School of Business.

" "